Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00613808 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers
A Phase 2 study, sponsored by Nitric BioTherapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00613808: Clinical Trial Phase 2 study, sponsored by Nitric BioTherapeutics.
NCT00613808 is a Phase 2 study that was terminated before completion, run by Nitric BioTherapeutics. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00613808, a Phase 2 study, was terminated before completion, sponsored by Nitric BioTherapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether nitric oxide (NO)gas is effective in the treatment of venous ulcers of the lower leg.
Interventions
- DRUG Nitric Oxide 200ppm Group B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-02 |
| Est. Completion | 2009-05 |
| Phase | Phase 2 |
Why NCT00613808 stopped before completion
NCT00613808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Nitric Oxide 200ppm Group B is the first listed.
NCT00613808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00613808 about?
NCT00613808 is a clinical study titled "Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers". The purpose of this study is to determine whether nitric oxide (NO)gas is effective in the treatment of venous ulcers of the lower leg.
What is the current status of trial NCT00613808?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2008-02. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00613808?
The interventions under investigation include: Nitric Oxide 200ppm Group B (DRUG).
Who is sponsoring clinical trial NCT00613808?
This trial is sponsored by Nitric BioTherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00613808's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia